GLOBAL SURVEY REPORT OUTLINES 2012 FOCUS 12 January 2012 / By Neil Darkes / Antibodies, Emerging Markets, Events, Flu, Partnering and Corporate strategy, Regulation and Policy, Therapeutic Vaccines / 0 comments
Re-balancing public perceptions of vaccination #wvclyon 10 October 2011 / By Neil Darkes / Antibodies, Flu, Partnering and Corporate strategy, Regulation and Policy, Uncategorized / 0 comments
ADITEC collaboration highlights new tech for R&D #wvclyon 10 October 2011 / By Neil Darkes / Uncategorized / 0 comments
#EuropeanCommission kicks off #wvclyon 2011 10 October 2011 / By Neil Darkes / Antibodies, Emerging Markets, Regulation and Policy, Uncategorized / 0 comments
TOP VALUE DRIVERS IN THE LIFE SCIENCE INDUSTRY 28 September 2011 / By Neil Darkes / Events, Partnering and Corporate strategy / 0 comments
Your 2012 funding prayers answered 27 September 2011 / By Neil Darkes / Emerging Markets, Events, Flu, Partnering and Corporate strategy, Therapeutic Vaccines / 0 comments
Speed Venturing at World Vaccine Congress Washington 18 August 2011 / By Neil Darkes / Events, Therapeutic Vaccines / 0 comments
2012 World Vaccine Congress Washington Survey Now Open 16 August 2011 / By Neil Darkes / Antibodies, Emerging Markets, Events, Flu, Partnering and Corporate strategy, Regulation and Policy, Therapeutic Vaccines / 0 comments
Poster Session Submissions NOW OPEN!!! 1 August 2011 / By Neil Darkes / Antibodies, Events, Regulation and Policy, Therapeutic Vaccines / 0 comments
2012 Vaccine Outsourcing Survey Results Posted – Download Here 1 August 2011 / By Neil Darkes / Events, Partnering and Corporate strategy / 0 comments
